Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Pediatric Cardiology

Lifelong Monitoring: Staying Ahead of Changes

At a Glance

Children with Carvajal syndrome need lifelong, individualized monitoring because heart rhythm problems and scarring can develop before pumping strength falls. ECGs, Holter monitors, echocardiograms, cardiac MRI, and family DSP testing help clinicians detect changes early.

Monitoring Carvajal syndrome is a lifelong commitment. Because the condition is progressive and can change as your child grows, regular check-ups are not just about checking current health—they are about detecting tiny changes before they become problems.

Your Child’s Care Team

Managing this rare condition requires a team of specialists who work together. This “medical neighborhood” typically includes:

  • Pediatric Electrophysiologist: A heart rhythm specialist who monitors for dangerous heartbeats (arrhythmias) [1].
  • Heart Failure Specialist: A cardiologist focused on the heart’s structure and pumping ability [2].
  • Dermatologist: To help manage the thickening skin on the hands and feet [3].
  • Genetic Counselor: To help you understand the DSP mutation and what it means for the rest of your family [4].

The Cardiac Monitoring Toolkit

A standard cardiac evaluation for Carvajal syndrome involves several tests. While a physical exam is important, these tools provide a look “under the hood.” An example schedule might be every 6 to 12 months, depending heavily on the child’s age, genotype, and symptoms [5].

  1. 12-Lead ECG: A quick snapshot of the heart’s electrical activity. Doctors look for specific patterns, such as T-wave inversions or low-voltage signals, which can be early signs of heart muscle changes [2][6].
  2. 24-Hour Holter Monitor: A wearable device that records every heartbeat for a full day. It is used to detect “silent” irregular rhythms, such as premature ventricular contractions (PVCs) or brief bursts of rapid heartbeats (nonsustained VT), which might not happen during a short office visit [7][1].
  3. Echocardiogram: A heart ultrasound that shows the heart’s size and how well it pumps blood (ejection fraction) [2].

Why Cardiac MRI is Essential

While echocardiograms are helpful, they are often used alongside a Cardiac MRI (CMR) with Late Gadolinium Enhancement (LGE), which is an important complementary tool for monitoring this specific condition [8][9].

  • Detecting Early Fibrosis: In many patients with DSP mutations, the heart muscle begins to develop scarring (fibrosis) before the heart actually starts to weaken. An echocardiogram usually cannot see this scar tissue, but a CMR can [8]. In one research cohort of patients with pathogenic DSP variants, 35% of those who underwent imaging had visible LGE even though their heart’s pumping function still looked normal [8].
  • Identifying “Hot Phases”: Some children experience episodes that feel like a heart infection (myocarditis), often called a “hot phase.” These episodes can cause chest pain and a rise in heart enzymes (troponin) [2][8]. A CMR can detect active inflammation and swelling during these phases, helping doctors adjust treatment immediately to protect the heart [10].

Cascade Genetic Screening: Protecting the Family

Because Carvajal syndrome is a genetic condition caused by a mutation in the DSP gene, finding it in one child has implications for the whole family. This process is called cascade screening [11].

  • Testing Siblings: Even if a sibling has normal hair and skin, they should be tested for the family’s specific DSP mutation. Because the condition is recessive, a sibling might be a “carrier” (one gene) or might have both genes but not yet show symptoms [12][4].
  • Testing Parents: Both biological parents are typically carriers of the gene. While carriers usually do not have symptoms, confirming their status helps clarify the genetic risk for future children or other relatives [11]. Testing positive for a variant requires genetic counseling, as some single variants can have cardiac implications.
  • The Power of Knowledge: Relatives who test negative for the known familial variants generally do not need ongoing cardiac monitoring for this condition [13]. Those who test positive can begin their own monitoring early, ensuring they stay ahead of any potential heart changes [11][14].

By keeping up with this rigorous monitoring schedule, you and your medical team can make informed decisions about medications, activity, and whether specialized devices like an ICD are needed [5][7].

Common questions in this guide

How often should a child with Carvajal syndrome have heart tests?
Follow-up is often scheduled every 6 to 12 months, but the timing depends on the child’s age, DSP genotype, symptoms, and previous results. Visits may include an ECG, Holter monitor, echocardiogram, or cardiac MRI as the care team recommends.
What can a cardiac MRI show in Carvajal syndrome?
A cardiac MRI can show fibrosis, or scarring, and active inflammation that an echocardiogram may not detect. Late gadolinium enhancement may appear before the heart’s pumping function decreases, helping the care team identify changes earlier.
What is a hot phase, and what should we do if it happens?
A hot phase is a myocarditis-like episode that may cause chest pain and a rise in troponin, a blood marker of heart injury. Ask the child’s cardiology team for an individualized urgent-action plan, and have new chest pain or other concerning symptoms assessed promptly.
Why does my child need a Holter monitor if the office ECG is normal?
An office ECG records a short period, while a 24-hour Holter monitor records every heartbeat during daily activities. It can detect intermittent or silent rhythm problems, including extra beats called PVCs and brief runs of nonsustained ventricular tachycardia, that may not occur during the visit.
Who in the family should have genetic testing after a DSP mutation is found?
Biological siblings and parents should discuss testing for the family’s specific DSP variant with a genetic counselor, and other relatives may also need evaluation. A positive result can support early monitoring, while a negative result for the known family variant generally means condition-specific cardiac monitoring is not needed.
Can a sibling have Carvajal syndrome without hair or skin changes?
Yes. A sibling may carry one altered DSP copy or have two altered copies without showing signs yet, so normal hair and skin do not rule out genetic risk. Testing for the known family variant can clarify whether monitoring is needed.
Which specialists usually monitor a child with Carvajal syndrome?
Care commonly includes a pediatric electrophysiologist or other cardiologist, a heart-failure specialist, a dermatologist, and a genetic counselor. The team coordinates rhythm checks, heart imaging, skin care, and family testing.

Get notified when new evidence is published on Carvajal syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    Genotype and cardiac outcome in patients with cardiocutaneous syndrome (Naxos disease variant: Carvajal syndrome).

    Binfadel M, Aleem MU, Alhabdan M, et al.

    Orphanet journal of rare diseases 2025; (20(1)):137 doi:10.1186/s13023-025-03612-8.

    PMID: 40108711
  2. 2

    Desmoplakin Cardiomyopathy in Pediatric Patients: A Distinct, Underrecognized Cohort of Arrhythmogenic Cardiomyopathy.

    Choi NH, Cherny S, Berul CI, et al.

    Circulation. Arrhythmia and electrophysiology 2024; (17(11)):e013114 doi:10.1161/CIRCEP.124.013114.

    PMID: 39523938
  3. 3

    Carvajal Syndrome- A Variant of Naxos Disease: A Case Report.

    Mandal KD, Shrestha PN, Ghimire A, et al.

    JNMA; journal of the Nepal Medical Association 2022; (60(246)):187-191 doi:10.31729/jnma.7102.

    PMID: 35210635
  4. 4

    Desmoplakin Cardiomyopathy Presenting as Recurrent Myocarditis Treated With Immunosuppression.

    Abdaem J, Leader N, Ballantyne BA, et al.

    JACC. Case reports 2025; (30(27)):104927 doi:10.1016/j.jaccas.2025.104927.

    PMID: 40767829
  5. 5

    Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy.

    Protonotarios A, Anastasakis A, Panagiotakos DB, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2016; (18(4)):610-6 doi:10.1093/europace/euv061.

    PMID: 25825460
  6. 6

    Clinical features and outcomes in carriers of pathogenic desmoplakin variants.

    Gasperetti A, Carrick RT, Protonotarios A, et al.

    European heart journal 2025; (46(4)):362-376 doi:10.1093/eurheartj/ehae571.

    PMID: 39288222
  7. 7

    Diagnostic Criteria and Disease Staging for Desmoplakin Cardiomyopathy.

    Smith E, Gasperetti A, Carrick RT, et al.

    medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.06.16.25329734.

    PMID: 40666337
  8. 8

    Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy.

    Smith ED, Lakdawala NK, Papoutsidakis N, et al.

    Circulation 2020; (141(23)):1872-1884 doi:10.1161/CIRCULATIONAHA.119.044934.

    PMID: 32372669
  9. 9

    Case report: Multiple biventricular aneurysms in arrhythmogenic cardiomyopathy.

    Lin J, Lu Z, Lin M, et al.

    Frontiers in cardiovascular medicine 2022; (9()):1034703 doi:10.3389/fcvm.2022.1034703.

    PMID: 36762301
  10. 10

    Recurrent myocarditis as a clinical gateway to desmoplakin cardiomyopathy: a case report.

    Reyes T RE, Vargas-Hernández DA, Cañón DP, Figueroa JF

    European heart journal. Case reports 2026; (10(3)):ytag062 doi:10.1093/ehjcr/ytag062.

    PMID: 41788433
  11. 11

    Clinical care of family members of patients with dilated cardiomyopathy.

    Verdonschot JAJ, Kaski JP, Asselbergs FW, et al.

    European heart journal 2025; (46(43)):4569-4582 doi:10.1093/eurheartj/ehaf571.

    PMID: 40902100
  12. 12

    Myocarditis Revealing a Pathogenic Desmoplakin (DSP) Variant: Implications for Genetic Testing Pathways.

    Reka B, Dungu JN

    Cureus 2026; (18(9)):e116569 doi:10.7759/cureus.116569.

    PMID: 42903300
  13. 13

    Cascade testing for inherited cardiac conditions: Risk perception and screening after a negative genetic test result.

    Fusco KM, Hylind RJ, Cirino AL, et al.

    Journal of genetic counseling 2022; (31(6)):1273-1281 doi:10.1002/jgc4.1602.

    PMID: 35763674
  14. 14

    Issues and Challenges in Diagnostic Sequencing for Inherited Cardiac Conditions.

    Walsh R, Cook SA

    Clinical chemistry 2017; (63(1)):116-128 doi:10.1373/clinchem.2016.254698.

    PMID: 27879323

This page provides general information about lifelong monitoring for Carvajal syndrome and is for informational purposes only; it does not constitute medical advice. Your child’s cardiology, genetics, and dermatology team should personalize testing, follow-up, and treatment decisions.